Compare the product scope, applications and research editions relevant to your next decision.
Pharma & Healthcare
5 editions27 December 2025
Pharma & Healthcare
5 editions21 December 2025
Pharma & Healthcare
5 editions26 December 2025
Pharma & Healthcare
5 editions20 December 2025
Pharma & Healthcare
Janus kinase inhibitors, also known as JAK inhibitors or jakinibs, are a type of medication that functions by inhibiting the activity of one or more of the Janus kinase family of enzymes (JAK1, JAK2, JAK3, TYK2), thereby interfering with the JAK-STAT signaling pathway.
5 editions2 January 2026
Pharma & Healthcare
5 editions19 December 2025
Pharma & Healthcare
5 editions2 January 2026
Pharma & Healthcare
Adrenoleukodystrophy (ALD) is a rare, genetic, X-linked metabolic disorder caused by mutations in the ABCD1 gene that result in a deficiency in a peroxisomal protein called adrenoleukodystrophy protein (ALDP).
5 editions27 December 2025
Pharma & Healthcare
5 editions1 January 2026
Pharma & Healthcare
Immune health products are health products that can improve immunity and promote metabolism.
5 editions29 December 2025
Pharma & Healthcare
Oral health supplements are ingestible, non-prescription nutrition products intended to act within the oral cavity and along the oro-mucosal–systemic axis as an adjunct to evidence-based dental care. The category encompasses capsules, powders, liquids, orodispersible tablets, lozenges, chewing gums, and oromucosal films formulated to shift biofilm ecology toward commensal dominance, improve enamel mineral homeostasis, and modulate gingival–periodontal inflammatory tone.…
5 editions21 December 2025
Pharma & Healthcare
5 editions19 December 2025